Last update 22 Nov 2024

Anti-NKG2DL gamma delta CAR-T cell therapy (Cytomed Therapeutics)

Overview

Basic Info

Drug Type
Universal CAR-T
Synonyms
Allogeneic NKG2DL-targeting CAR γδ T Cells, CAR-grafted gamma delta T cell therapy(CytoMed Therapeutics Pte Ltd.), CTMN2D Cytomed Therapeutics
+ [2]
Target
Mechanism
ULBP1 inhibitors(UL16 binding protein 1 inhibitors), Gene transference, T lymphocyte replacements
Inactive Indication-
Originator Organization
Active Organization
Inactive Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced cancerPhase 1
SG
19 Nov 2024
Advanced Malignant Solid NeoplasmPhase 1
SG
19 Nov 2024
Hematologic NeoplasmsPhase 1
SG
19 Nov 2024
Refractory CancerPhase 1
SG
19 Nov 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free